DiviDrip · PYXS

PYXS — Pyxis Oncology, Inc.

PYXS is Pyxis Oncology, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $3.89. Market cap: $324M. Capital Quality Rank: 12/100 — Capital destroyer.

Stock snapshot

Price$3.89
Market cap$324M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)12 / 100 · Capital destroyer
ROIC (TTM)-175.5%
Shareholder buyback yield-5.95%
Altman Z-score zoneDistress

About PYXS

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Listed2021Employees56HQBoston, MASectorHealthcareWebsitepyxisoncology.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PYXS. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PYXS's current stock price?

PYXS (Pyxis Oncology, Inc.) is currently trading at $3.89.

Does PYXS pay a dividend?

PYXS (Pyxis Oncology, Inc.) does not currently pay a regular dividend.

What is PYXS's Capital Quality Rank?

PYXS has a Capital Quality Rank of 12/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PYXS in DiviDrip

Add PYXS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow